D-0449

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameD-0449
Drug Alias Nameosteoporosis therapy (Yissum)osteogenesis peptide (Yissum)D-0449
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBone synthesis stimulants
TargetsUpdating
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesYissum Research Development Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYissum Research Development Company
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A